Nightingale Announces Completion of Previously Announced Debenture Exchange and Conversion

/NOT FOR DISTRIBUTION IN THE UNITED STATES/

MARKHAM, ON, Dec. 18, 2013 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) ("Nightingale" or the "Corporation") announced that it had completed the exchange and/or conversion of its outstanding 12% unsecured convertible debentures (the "Series Bs"), as described in its November 21, 2013 press release (the "Series Bs Exchange/Conversion").

Pursuant to the Series Bs Exchange/Conversion, Nightingale exchanged an aggregate principal amount of $228,000 in Series Bs for the remaining available aggregate principal amount of its 10% senior secured convertible debentures (the "Series Cs"), which were issuable pursuant to a trust indenture dated March 12, 2013.

As well, as part of the Series Bs Exchange/Conversion and at the election of the Series Bs holders, the Corporation issued 8,448,000 common shares of the Corporation (the "Common Shares") upon the conversion of an aggregate principal amount of $2,112,000 in Series Bs at a reduced conversion price of $0.25 per Common Share, rather than the Series Bs' original conversion price of $0.35 per Common Share. The total number of Common Shares currently issued and outstanding is 84,758,915.

Certain insiders of the Corporation participated in the Series Bs Exchange/Conversion and thereby elected to receive a total of 4,600,000 Common Shares upon the conversion of their Series Bs.

The Series Bs Exchange/Conversion remains subject to final approval of the TSX-V.

About Nightingale

Nightingale is one of the fastest growing health care service and software companies in North America and is recognized as an industry leader in Web-based clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management and transcription, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected. www.nightingalemd.ca

Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect",  "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: the ability of Nightingale to obtain all required regulatory approval of the Series Bs Exchange/Conversion; risks associated with obtaining the required Exchange and shareholder approvals of the Series Bs Exchange/Conversion; risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully secure customer contracts and the timing of securing such contracts; the ability of Nightingale to complete and successfully integrate its acquisitions on an accretive basis, Nightingale's access to debt and capital facilities, including compliance with current debt arrangements; the existence of present and possible future government regulation; the significant competition that exists in the medical software industry; the early stage of Nightingale's business, and risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding.  All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding future trends in healthcare spending, economic conditions affecting Nightingale and North American economies; Nightingale's ability to continue to fund its business, rates of customer defaults, relationships with, and payments to lenders, as well as Nightingale's operating cost structure.

Although Nightingale has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Nightingale does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws. Further information on Nightingale Informatix Corporation is available at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Nightingale Informatix Corporation

about Nightingale, contact:

Peter Cauley
Chief Financial Officer
Nightingale Informatix Corporation
Tel: [phone]
[email protected]

Investor Inquiries
Marc Lakmaaker
Senior Account Executive, TMX Equicom
Tel: [phone] ext. 248
[email protected]